Cerenome Reported Q3 Billings of $1.55 Million
The Houston-based diagnostics firm recorded gross billings for 222 CNSide tests during the third quarter of 2026.
Live Poll
Do you believe expanding diagnostic testing coverage improves patient access to necessary care?